Colleen Eicher, APRN
Primary Care · Hartville, OHNPI 1821766270
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,408, more than ten times the $127 reported in 2022.
Across 122 payments — averaging $23.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genmab U.S., Inc.$360
- Merck$329
- Daiichi Sankyo Inc.$295
- Eisai Inc.$250
- Novartis$119
- Astellas Pharma US Inc$113
- plus $1K from 34 others
What the payments were for
- Food & beverage$2,81197%
- Education$903%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genmab U.S., Inc. | 11 | $360 |
| Merck | 15 | $329 |
| Daiichi Sankyo Inc. | 10 | $295 |
| Eisai Inc. | 9 | $250 |
| Novartis | 5 | $119 |
| Astellas Pharma US Inc | 5 | $113 |
| AbbVie | 4 | $98 |
| Johnson & Johnson | 5 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $90 |
| Pharmacosmos Therapeutics Inc. | 4 | $85 |
| Lilly USA, LLC | 3 | $75 |
| Bayer | 4 | $75 |
| AstraZeneca | 3 | $69 |
| Gilead(2 entities) | 3 | $69 |
| Stemline Therapeutics Inc. | 2 | $60 |
| Genentech USA, Inc. | 3 | $58 |
| GSK | 2 | $54 |
| Caris MPI, Inc. | 2 | $42 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| EMD Serono, Inc. | 2 | $40 |
| Bristol Myers Squibb | 2 | $39 |
| Sanofi | 2 | $37 |
| Servier Pharmaceuticals LLC | 2 | $33 |
| Blueprint Medicines Corporation | 1 | $32 |
| Puma Biotechnology, Inc. | 2 | $29 |
| Tersera Therapeutics LLC | 1 | $28 |
| Incyte Corporation | 1 | $27 |
| Invivyd Inc | 1 | $27 |
| Pfizer | 1 | $26 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Sobi, Inc | 1 | $20 |
| Legend Biotech USA Inc. | 1 | $20 |
| Deciphera Pharmaceuticals Inc. | 1 | $20 |
| Octapharma USA, Inc. | 1 | $19 |
| Immunogen, Inc. | 1 | $17 |
| Iovance Biotherapeutics, Inc. | 1 | $17 |
| Janssen Scientific Affairs, LLC | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Fresenius Kabi USA, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TIVDAK$125
How this compares
$2,901 in reported general payments places this provider in the 85th percentile of 321 primary care providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 30 | $791 |
| Prochlorperazine Maleate | 17 | $215 |
| Dexamethasone | 28 | $156 |
| Nystatin | 11 | $137 |
| Potassium Chloride | 17 | $110 |
| Oxycodone Hcl | 19 | $104 |
| Gabapentin | 21 | $90 |
| Fluconazole | 22 | $90 |
| Lorazepam | 26 | $43 |
Paid to pharmacies, not to this prescriber.
Other primary care in Hartville
- Adine EdwardsSpringfield$14K
- Kelly McKenna TaulbeeHamilton$12K
- Lindsay ChappellFairlawn$11K
- Laura HolligerNorth Canton$10K
- Caitlyn FrantzDayton$10K
- Brandy RichardsCleveland$8K
- Regan HeagenFindlay$8K
- Zachary HaleBeavercreek$7K
- Katherine ElliotWesterville$7K
- Stephanie EmmettMayfield Heights$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.